Ab externo open conjunctiva XEN® 63 μm: a novel surgical alternative in uveitic glaucoma-a case report.

IF 2.3 Q1 OPHTHALMOLOGY
Yann Bertolani, Júlia Angrill-Valls, Laura Sánchez-Vela, Eric Kirkegaard-Biosca, Antonio Dou, Nieves Martín-Begué, Marta Castany
{"title":"Ab externo open conjunctiva XEN<sup>®</sup> 63 μm: a novel surgical alternative in uveitic glaucoma-a case report.","authors":"Yann Bertolani, Júlia Angrill-Valls, Laura Sánchez-Vela, Eric Kirkegaard-Biosca, Antonio Dou, Nieves Martín-Begué, Marta Castany","doi":"10.1186/s12348-025-00493-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To describe the efficacy and safety of the ab externo open-conjunctiva XEN<sup>®</sup> 63 μm gel stent in uveitic glaucoma.</p><p><strong>Case presentation: </strong>A case report of a 15-year-old patient with bilateral uncontrolled uveitic glaucoma secondary to chronic anterior uveitis was presented. Several medical ophthalmological and rheumatological evaluation visits were conducted. Preoperative intraocular pressure was 28 mmHg in the right eye and 32 mmHg in the left eye. She underwent a trabeculectomy in her right eye developing hypotonic maculopathy and decompression retinopathy, requiring surgical revision. Considering the complications endured in the right eye, it was decided to perform an ab externo open-conjunctiva XEN<sup>®</sup> 63 μm implant in her left eye with no postoperative complications. Postoperative course was uneventful with well-controlled intraocular pressure (11 mmHg) and no progression of glaucomatous damage, one year after the procedure. Anterior segment optical coherence tomography evidenced a well-functioning and non-encapsulated bleb along the follow up. Eventually, there were no postoperative uveitic episodes, with 40 mg Adalimumab as a steroid-sparing agent.</p><p><strong>Conclusion: </strong>Uveitic glaucoma presents both clinical and therapeutic challenges. Traditional surgery such as trabeculectomy may entail postoperative complications such as hypotonic maculopathy and decompression retinopathy. This is the first case reporting the efficacy and safety of ab externo open-conjunctiva XEN<sup>®</sup> 63 μm implant in uveitic glaucoma, highlighting its potential usefulness in such clinical scenarios.</p>","PeriodicalId":16600,"journal":{"name":"Journal of Ophthalmic Inflammation and Infection","volume":"15 1","pages":"37"},"PeriodicalIF":2.3000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11985823/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmic Inflammation and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12348-025-00493-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To describe the efficacy and safety of the ab externo open-conjunctiva XEN® 63 μm gel stent in uveitic glaucoma.

Case presentation: A case report of a 15-year-old patient with bilateral uncontrolled uveitic glaucoma secondary to chronic anterior uveitis was presented. Several medical ophthalmological and rheumatological evaluation visits were conducted. Preoperative intraocular pressure was 28 mmHg in the right eye and 32 mmHg in the left eye. She underwent a trabeculectomy in her right eye developing hypotonic maculopathy and decompression retinopathy, requiring surgical revision. Considering the complications endured in the right eye, it was decided to perform an ab externo open-conjunctiva XEN® 63 μm implant in her left eye with no postoperative complications. Postoperative course was uneventful with well-controlled intraocular pressure (11 mmHg) and no progression of glaucomatous damage, one year after the procedure. Anterior segment optical coherence tomography evidenced a well-functioning and non-encapsulated bleb along the follow up. Eventually, there were no postoperative uveitic episodes, with 40 mg Adalimumab as a steroid-sparing agent.

Conclusion: Uveitic glaucoma presents both clinical and therapeutic challenges. Traditional surgery such as trabeculectomy may entail postoperative complications such as hypotonic maculopathy and decompression retinopathy. This is the first case reporting the efficacy and safety of ab externo open-conjunctiva XEN® 63 μm implant in uveitic glaucoma, highlighting its potential usefulness in such clinical scenarios.

Abstract Image

Abstract Image

Abstract Image

体外开放结膜XEN®63 μm:一种治疗青光眼的新手术选择- 1例报告。
目的:观察XEN®63 μm凝胶支架治疗青光眼的疗效和安全性。病例报告:一个15岁的病人,继发于慢性前葡萄膜炎的双侧不受控制的葡萄膜性青光眼。进行了几次眼科和风湿病医学评估访问。术前右眼眼压28 mmHg,左眼眼压32 mmHg。她接受了右眼小梁切除术,出现低张力黄斑病变和减压性视网膜病变,需要手术修复。考虑到右眼的并发症,我们决定在她的左眼进行体外开放结膜XEN®63 μm植入,没有术后并发症。术后一年,眼压(11 mmHg)控制良好,青光眼损伤无进展。前段光学相干断层扫描在随访中发现一个功能良好且未被包裹的气泡。最终,没有术后葡萄膜发作,40mg阿达木单抗作为类固醇节约剂。结论:葡萄膜性青光眼的临床和治疗都面临挑战。传统手术如小梁切除术可能导致术后并发症,如低张力黄斑病变和减压性视网膜病变。这是首例报道体外开放结膜XEN®63 μm植入体治疗青光眼的疗效和安全性的病例,突出了其在此类临床情况下的潜在用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
3.40%
发文量
39
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信